There were 2,390 press releases posted in the last 24 hours and 440,369 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
First Participants Enrolled in the AriBio USA Phase 3 Registration Trial to Evaluate AR1001 in Early Alzheimer's Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image